SA
ALNY logo
Alnylam Pharmaceuticals, Inc.(ALNY)
Closing price · checked 4:31 PM ETAbout this dataData status
$147.82▼-1.58 (-1.06%)
After Hours:$147.00-0.82 (-0.55%)· 4:31 PM ET

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 28.4 · elevated volatility

Overview →

Alnylam Pharmaceuticals, Inc. (ALNY)

CapEx to Operating CF

23.01%

TTM · Retrieved:

ALNY logo

ALNY CapEx to Operating CF

Current (TTM)23.01%
ALNY CapEx/OCF (-43.97% → 23.01%)
High-resolution chart · PNG

What is capex to operating cf?

Capital expenditure as percentage of operating cash flow.

ALNY capex to operating cf history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Alnylam Pharmaceuticals, Inc. CapEx to Operating CF — Annual fiscal periods
Period endingCapEx to Operating CF
11.2%
-412.3797%
59.7287%
-13.3129%
-11.9016%
-11.4415%
-50.3385%
-22.553%
-27.2238%
-20.9804%
-6.8468%
-5.4099%
-5.8348%
-7.2209%
-1.4827%
-5.6106%
-6.8598%
16.4358%
3.963%
-20.2436%
-11.8107%
-46.0194%
-24.314%
-43.975%

Frequently asked questions: ALNY capex to operating cf

What is Alnylam Pharmaceuticals, Inc. (ALNY)'s current capex to operating cf?

Alnylam Pharmaceuticals, Inc. (ALNY)'s latest reported capex to operating cf (TTM) is 23.01% as of Nov 19, 2026. Capital expenditure as percentage of operating cash flow.

How much historical capex to operating cf data is available for ALNY?

Stock Alarm Pro provides 24 dated annual fiscal periods observations for Alnylam Pharmaceuticals, Inc. (ALNY)'s capex to operating cf, allowing investors to analyze multi-year trends and cycle inflection points in Chart Studio.

How can I compare ALNY's capex to operating cf to peers or set an alert?

You can open ALNY's capex to operating cf in Stock Alarm Pro Chart Studio to overlay price and valuation multiples, or set real-time alerts on ALNY delivered by push, email, or phone call.

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.